Historical source coverage

2010

29 selected records with a cited source date in 2010. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2010 by record type

3 types

December 2010

4 records

Clinical trials · Cerebrolysin

ClinicalTrials.gov record NCT00840671

PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.

Source: ClinicalTrials.gov ↗

→

Regulatory · Bivalirudin

Federal Register notice 2010-31583

The Federal Register published notice 2010-31583, attributed to FDA and its parent HHS department, on 2010-12-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ANGIOMAX,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

Source: Federal Register via GovInfo ↗

→

November 2010

5 records

Literature metadata · Nesiritide

Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.

PubMed lists PMID 17461696 in Pharmacotherapy as Comment, Journal Article, Review, with publication-date metadata of 2007-05 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semax

PubMed record PMID 11569188

PeptideScanner retained PubMed bibliographic metadata for PMID 11569188 at 2026-07-30T22:26:16.761Z. PubMed recorded a metadata revision date of 2010-11-18 and an Entrez history date of 2001-09-25. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · CJC-1295

PubMed record PMID 15817669

PeptideScanner retained PubMed bibliographic metadata for PMID 15817669 at 2026-07-30T22:26:16.765Z. PubMed recorded a metadata revision date of 2010-11-18 and an Entrez history date of 2005-04-09. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Tesamorelin

Drugs@FDA application BLA022505

The official Drugs@FDA dataset lists original submission 1 for BLA 022505 with status AP dated 2010-11-10, and names tesamorelin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

October 2010

1 record

September 2010

3 records

Literature metadata · Liraglutide

PubMed record PMID 20861602

PeptideScanner retained PubMed bibliographic metadata for PMID 20861602 at 2026-07-30T22:26:16.803Z. PubMed recorded a metadata revision date of 2010-09-23 and an Entrez history date of 2010-09-24. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT00460382

PeptideScanner retained ClinicalTrials.gov record NCT00460382 at 2026-11-16T01:41:15.051Z. Its registry update date was 2010-09-17, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

August 2010

2 records

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00259298

PeptideScanner retained ClinicalTrials.gov record NCT00259298 at 2026-07-30T22:25:23.113Z. Its registry update date was 2010-08-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT01178996

PeptideScanner retained ClinicalTrials.gov record NCT01178996 at 2026-11-15T22:10:40.222Z. Its registry update date was 2010-08-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

June 2010

2 records

Literature metadata · PEG-MGF

Proteinase B disruption is required for high level production of human mechano-growth factor in Saccharomyces cerevisiae.

PubMed lists PMID 20530970 in Journal of molecular microbiology and biotechnology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-06-08 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

May 2010

3 records

Regulatory · Desmopressin

Federal Register notice 2010-11038

The Federal Register published notice 2010-11038, attributed to FDA and its parent HHS department, on 2010-05-11. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

April 2010

1 record

March 2010

5 records

Clinical trials · Thymosin beta-4

ClinicalTrials.gov record NCT00832091

PeptideScanner retained ClinicalTrials.gov record NCT00832091 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-03-30, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

Source: ClinicalTrials.gov ↗

→

Regulatory · Tesamorelin

Federal Register notice 2010-6169

The Federal Register published notice 2010-6169, attributed to FDA and its parent HHS department, on 2010-03-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Source: Federal Register via GovInfo ↗

→

Regulatory · Degarelix

Federal Register notice 2010-4159

The Federal Register published notice 2010-4159, attributed to FDA and its parent HHS department, on 2010-03-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FIRMAGON,” and PeptideScanner's exact reviewed identity mapping connects the document to Degarelix.

Source: Federal Register via GovInfo ↗

→

February 2010

1 record

Clinical trials · Thymosin beta-4

ClinicalTrials.gov record NCT00382174

PeptideScanner retained ClinicalTrials.gov record NCT00382174 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-02-01, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

Source: ClinicalTrials.gov ↗

→

January 2010

2 records

Regulatory · Tesamorelin

Federal Register notice 2010-785

The Federal Register published notice 2010-785, attributed to FDA and its parent HHS department, on 2010-01-19. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Source: Federal Register via GovInfo ↗

→